Physical ValidationHalmos Labs
APIMCP
Submit request
Browse all

OPL Pharmaceuticals

United States

Request a quoteWebsite (opens in a new tab)

OPL Pharmaceuticals is a leader in developing NDA products through the 505(b)(2) pathway, leveraging proprietary timed-release, once-daily (QD) oral drug delivery, and oral peptide delivery platforms to extend patent protection, enhance NCE developability, and create differentiated products. Source (opens in a new tab)

Headquarters
US